Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
111,633,839
-
Number of holders
-
237
-
Total 13F shares, excl. options
-
122,283,963
-
Shares change
-
-7,560,479
-
Total reported value, excl. options
-
$1,375,271,472
-
Value change
-
-$248,054,960
-
Put/Call ratio
-
71%
-
Number of buys
-
133
-
Number of sells
-
-137
-
Price
-
$11.25
Significant Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q4 2024
344 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock as of Q4 2024.
Evolent Health, Inc. - Class A Common Stock (EVH) has 237 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 122,283,963 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (11,171,199 shares), WELLINGTON MANAGEMENT GROUP LLP (10,436,495 shares), BlackRock, Inc. (9,323,234 shares), Engaged Capital LLC (5,404,768 shares), CADIAN CAPITAL MANAGEMENT, LP (5,225,001 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (4,781,131 shares), EVENTIDE ASSET MANAGEMENT, LLC (4,552,306 shares), FMR LLC (4,476,482 shares), Camber Capital Management LP (4,000,000 shares), and Granahan Investment Management, LLC (3,673,710 shares).
This table shows the top 237 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.